Table 3.
Comparison of bleeding quantity (mean ± SD).
Group 1 Adding Norethisterone Acetate | Group 2 Doubling the Dose | Group 3 No Change | p-Value * | ||
---|---|---|---|---|---|
Bleeding Quantity at baseline (questionnaire 1) on a scale of 10 ˣ | 4.3 ± 1.7 | 1.6 ± 4.1 | 4.0 ± 1.6 | 0.703 1 | |
Difference from baseline to: | 2 weeks | 5.97 ± 3.39 | 3.75 ± 4.65 | 5.03 ± 3.25 | 0.294 2 |
4 weeks | 6.57 ± 3.33 | 4.35 ± 4.99 | 5.19 ± 3.56 | 0.091 3 | |
6 weeks | 6.72 ± 2.86 | 5.39 ± 4.66 | 5.52 ± 3.29 | 0.246 4 |
ˣ Data analysis was conducted by correcting the five-and seven-point Likert scale responses to a ten-point scale of inverse quantity. * p value by Kruskal–Wallis (First questionnaire) and by one-way ANOVA (Subsequent questionnaires). 1 Insignificant difference between groups 1 and 3 (p = 0.703). 2 Insignificant difference between groups 1 and 3 (p = 0.294). 3 Insignificant difference between groups 1 and 3 (p = 0.094). 4 Insignificant difference between groups 1 and 3 (p = 0.246).